Myocardial, Pericardial Diseases and Cardiomyopathy

Cardiac Troponin Is Infrequently Tested at Emergency Department Visits With Suspected Acute Ischemic Stroke Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD Letter by Kornelius Regarding Article, “Cardiovascular Disease in Anabolic Androgenic Steroid Users” Interaction Between Chronotype and the Timing of Antihypertensive Medication on Cardiovascular Events and Death Response by Zweck and Møller to Letter Regarding Article, “Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial” Cannabis Use Linked to Substantial Heart Risks Recurrent Pericarditis for Professionals Post-Myocardial Infarction Psychological Distress Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes